Metadata
- Name
- A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Children
- Repository
- ClinicalTrials.gov
- Identifier
- clinicaltrials:NCT02548078
- Description
- The purpose of this study is to assess the safety and reactogenicity of a single IM dose of
the GSK3390107A (ChAd3 EBO-Z) vaccine, overall and in children aged 1 to 5, 6 to 12, and 13
to 17 years, separately.
Considering the risk of exposure to Ebola and the potential (based on animal data) for the
investigational GSK3390107A (ChAd3-EBO-Z) vaccine to afford at least partial protection, all
children in the study will receive the investigational GSK3390107A (ChAd3 EBO-Z) vaccine. The
children in the Group GSK3390107A+Nimenrix will receive the investigational GSK3390107A
(ChAd3-EBO-Z) vaccine at Day 0 of the study, whereas the children in the Group
Nimenrix+GSK3390107A will receive Nimenrix at Day 0 (as a control). At Month 6, the children
in the Group Nimenrix+GSK3390107A will receive the investigational GSK3390107A (ChAd3-EBO-Z)
vaccine (provided that no safety concerns are raised), whereas the children in the Group
GSK3390107A+Nimenrix will receive Nimenrix. - Data or Study Types
- clinical trial
- Source Organization
- Unknown
- Access Conditions
- available
- Year
- 2015
- Access Hyperlink
- https://clinicaltrials.gov/ct2/show/NCT02548078
Distributions
- Encoding Format: HTML ; URL: https://clinicaltrials.gov/ct2/show/results/NCT02548078